1. Home
  2. COEP vs KNDI Comparison

COEP vs KNDI Comparison

Compare COEP & KNDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Coeptis Therapeutics Holdings Inc.

COEP

Coeptis Therapeutics Holdings Inc.

HOLD

Current Price

$11.72

Market Cap

72.7M

Sector

Health Care

ML Signal

HOLD

KNDI

Kandi Technologies Group Inc

HOLD

Current Price

$0.95

Market Cap

67.8M

ML Signal

HOLD

Company Overview

Basic Information
Metric
COEP
KNDI
Founded
2017
2002
Country
United States
China
Employees
7
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Auto Manufacturing
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
72.7M
67.8M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
COEP
KNDI
Price
$11.72
$0.95
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
32.8K
68.3K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.32
$0.78
52 Week High
$21.41
$1.77

Technical Indicators

Market Signals
Indicator
COEP
KNDI
Relative Strength Index (RSI) 45.69 44.13
Support Level $10.98 $0.91
Resistance Level $13.23 $0.95
Average True Range (ATR) 0.94 0.04
MACD 0.08 -0.01
Stochastic Oscillator 41.06 43.18

Price Performance

Historical Comparison
COEP
KNDI

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

About KNDI Kandi Technologies Group Inc

Kandi Technologies Group Inc is engaged in developing, manufacturing, and commercializing fully electric vehicle products and related technologies. Its products mainly consist of EV parts, EV products, and off-road vehicles, including All-Terrain Vehicles (ATVs), UTVs, go-karts, electric scooters, electric self-balancing scooters, and associated parts, and Lithium-ion cells, etc. The company generates maximum revenue from the sale of Off-road vehicles and associated parts. Geographically, it derives maximum revenue from the United States and other countries, followed by China.

Share on Social Networks: